In this report, the United States Veterinary Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Veterinary Therapeutics in these regions, from 2012 to 2022 (forecast). United States Veterinary Therapeutics market competition by top manufacturers/players, with Veterinary Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Bayer AG Boehringer Ingelheim GmbH Ceva Sante Animale Dechra Pharmaceuticals PLC Eli Lilly and Company (Elanco Animal Health) Merck Animal Health Sanofi (Merial Animal Health) Virbac Vetoquinol S.A. Zoetis, Inc. On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into By Drugs Anti-inflammatory Parasiticides Other By Vaccines Inactivated Vaccines Live Attenuated Vaccines Recombinant Vaccines By Medicated Feed Additives Amino Acids Antibiotics On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospitals Veterinary Clinics Drug Stores If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents United States Veterinary Therapeutics Market Report 2017 1 Veterinary Therapeutics Overview 1.1 Product Overview and Scope of Veterinary Therapeutics 1.2 Classification of Veterinary Therapeutics by Product Category 1.2.1 United States Veterinary Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Veterinary Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Anti-inflammatory 1.2.4 Parasiticides 1.2.5 Other 1.3 United States Veterinary Therapeutics Market by Application/End Users 1.3.1 United States Veterinary Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospitals 1.3.3 Veterinary Clinics 1.3.4 Drug Stores 1.4 United States Veterinary Therapeutics Market by Region 1.4.1 United States Veterinary Therapeutics Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Veterinary Therapeutics Status and Prospect (2012-2022) 1.4.3 Southwest Veterinary Therapeutics Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Veterinary Therapeutics Status and Prospect (2012-2022) 1.4.5 New England Veterinary Therapeutics Status and Prospect (2012-2022) 1.4.6 The South Veterinary Therapeutics Status and Prospect (2012-2022) 1.4.7 The Midwest Veterinary Therapeutics Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Veterinary Therapeutics (2012-2022) 1.5.1 United States Veterinary Therapeutics Sales and Growth Rate (2012-2022) 1.5.2 United States Veterinary Therapeutics Revenue and Growth Rate (2012-2022) 2 United States Veterinary Therapeutics Market Competition by Players/Suppliers 2.1 United States Veterinary Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Veterinary Therapeutics Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Veterinary Therapeutics Average Price by Players/Suppliers (2012-2017) 2.4 United States Veterinary Therapeutics Market Competitive Situation and Trends 2.4.1 United States Veterinary Therapeutics Market Concentration Rate 2.4.2 United States Veterinary Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Veterinary Therapeutics Manufacturing Base Distribution, Sales Area, Product Type 3 United States Veterinary Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Veterinary Therapeutics Sales and Market Share by Region (2012-2017) 3.2 United States Veterinary Therapeutics Revenue and Market Share by Region (2012-2017) 3.3 United States Veterinary Therapeutics Price by Region (2012-2017) 4 United States Veterinary Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Veterinary Therapeutics Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Veterinary Therapeutics Revenue and Market Share by Type (2012-2017) 4.3 United States Veterinary Therapeutics Price by Type (2012-2017) 4.4 United States Veterinary Therapeutics Sales Growth Rate by Type (2012-2017) 5 United States Veterinary Therapeutics Sales (Volume) by Application (2012-2017) 5.1 United States Veterinary Therapeutics Sales and Market Share by Application (2012-2017) 5.2 United States Veterinary Therapeutics Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Veterinary Therapeutics Players/Suppliers Profiles and Sales Data 6.1 Bayer AG 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Veterinary Therapeutics Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Bayer AG Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Boehringer Ingelheim GmbH 6.2.2 Veterinary Therapeutics Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Ceva Sante Animale 6.3.2 Veterinary Therapeutics Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Ceva Sante Animale Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Dechra Pharmaceuticals PLC 6.4.2 Veterinary Therapeutics Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Eli Lilly and Company (Elanco Animal Health) 6.5.2 Veterinary Therapeutics Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Merck Animal Health 6.6.2 Veterinary Therapeutics Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Merck Animal Health Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Sanofi (Merial Animal Health) 6.7.2 Veterinary Therapeutics Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Virbac 6.8.2 Veterinary Therapeutics Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Virbac Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Vetoquinol S.A. 6.9.2 Veterinary Therapeutics Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Vetoquinol S.A. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Zoetis, Inc. 6.10.2 Veterinary Therapeutics Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Zoetis, Inc. Veterinary Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 7 Veterinary Therapeutics Manufacturing Cost Analysis 7.1 Veterinary Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Veterinary Therapeutics 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Veterinary Therapeutics Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Veterinary Therapeutics Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Veterinary Therapeutics Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Veterinary Therapeutics Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Veterinary Therapeutics Sales Volume Forecast by Type (2017-2022) 11.3 United States Veterinary Therapeutics Sales Volume Forecast by Application (2017-2022) 11.4 United States Veterinary Therapeutics Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer